Elevated Expression of the Immune Checkpoint Ligand CD276 (B7-H3) in Urothelial Carcinoma Cell Lines Correlates Negatively with the Cell Proliferation.
Niklas HarlandFlorian B MaurerTanja AbruzzeseCornelia BockIvonne-Aidee Montes-MojarroFalko FendWilhelm K AicherArnulf StenzlBastian AmendPublished in: International journal of molecular sciences (2022)
tumor (stem) cells may evade immune surveillance. However, cancer therapy targeting CD276 may be effective in the treatment of slow proliferating tumor cells.